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We describe a second reported case of human
infection caused by Raoultella terrigena.
Introduction
Raoultella terrigena (previously known as Klebsiella
terrigena) is a rarely encountered gram-negative
bacterium and mainly reported as aquatic and
soil organism.
1 However, in 2007 the ﬁrst human
infection caused by this organism was reported in
a 45-year-old patient who developed endocarditis
due to R. terrigena post liver transplant.
2 No other
case reports of infections caused by this organism
have been published, and the clinical spectrum of
diseases caused by this organism is unknown.
The correct identiﬁcation of R. terrigena is not
easily accomplished in most clinical microbiology
laboratories, and isolates can be easily misidenti-
ﬁed as Klebsiella pneumoniae or other Klebsiella
species.
3
We describe a patient with sepsis with a
primary infection by R. terrigena.
Case report
Our patient was a 69-year-old man who under-
went pancreatic resection (pancreaticoduodenect-
omy, Whipple’s procedure) for pancreatic cancer.
An abdominal drain was left in situ, and post-
operatively he made good progress until day
nine when he developed fever and diarrhoea. A
stool sample was positive for Clostridium difﬁcile
toxin and metronidazole was commenced orally.
A computerized tomography (CT) scan of the
abdomen showed a large 30 × 16 cm collection
in the pelvis and the abdominal drain was
repositioned to drain the collection. Drain ﬂuid
culture yielded Klebsiella pneumoniae (sensitive to
co-amoxiclavulanic acid, cefotaxime, cefradine,
ciproﬂoxacin, gentamicin and imipenem) and
anaerobes, while blood culture did not show any
growth.
By day 12, being more unwell with severe
sepsis needing inotropic support, he was trans-
ferred to the intensive care unit. He received a
stat dose of intravenous gentamicin 320 mg and
vancomycin 1 gm, and was commenced empiri-
cally on imipenem 500 mg 6-hourly. The following
day, a blood culture yielded gram-negative rods,
later identiﬁed as R. terrigena sensitive to
co-amoxiclavulanic acid, cefotaxime, cefradine,
ciproﬂoxacin, gentamicin and imipenem. Drain
ﬂuid also grew R. terrigena with the same sensi-
tivities as in blood culture and Candida spp. The
imipenemwaschangedtopiperacillin-tazobactam,
in accordance with the local policy, and he
responded to therapy. By day 15 he was able to be
discharged back to the ward, where piperacillin-
tazobactam was continued.
Over the subsequent three weeks, he developed
ab a c t e r e m i aw i t hEnterococcus durans, necessitating
addition of intravenous vancomycin. A repeat CT
scan excluded a persistent abdominal collection
but now showed a thrombus in the inferior vena
cava. The abdominal drain was removed.
He was ﬁnally discharged home 50 days after
admission.
Discussion
First described in 1981 as Klebsiella terrigena,
4
R. terrigena is a member of the family Enterobac-
teriaciae. Klebsiellae are non-motile, rod-shaped,
gram-negative bacteria with a prominent poly-
saccharide capsule that accounts for the large
appearance of the organism on gram stain, and
provides resistance against many host defense
mechanisms.
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1R. terrigena was ﬁrst isolated in 1981 from soil
and water.
4,6 For many years following the ﬁrst
description of this new species no human isolates
were reported. In 1991 R. terrigena was isolated
form the stool of healthy humans, with a carriage
rate of 0.9% for 5377 different stool specimens
examined.
7 The signiﬁcance of the isolate was
uncertain, until in 1992 when 2355 clinical isolates
(mostly from respiratory tract) of Klebsiella were
subjected to additional tests and 10 isolates
(0.4%) of R. terrigena were identiﬁed. However
the signiﬁcance of this isolation, and whether
R. terrigena causes monomicrobial infections or
participates in polymicrobial infections remained
to be clariﬁed.
Our case is the second reported case of actual
clinical infection caused by R. terrigena. The ﬁrst
reported clinical infection was in 2007 when a
45-year-old old patient post liver transplant devel-
oped pneumonia, sepsis and endocarditis due to
R. terrigena. Extended spectrum beta-lactamase
(ESBL) producing R. terrigena and multi-resistant
coagulase negative staphylococci (MRCNS) were
isolated from the sputum. On postmortem exam-
ination, the aortic valve was found to be destroyed
by endocarditis and samples grew MRCNS and
ESBL-producing R. terrigena. Notably this patient
was colonized with ESBL producing R. terrigena
prior to liver transplant and prophylaxis with
piperacillin-tazobactam was unable to eradicate
the organism.
2
Our case developed sepsis due to R. terrigena
after having a laprotomy which was complicated
by intra-abdominal collection. Initial drain ﬂuid
samples grew Klebsiella pneumoniae and mixed ane-
robes and later on blood cultures and drain ﬂuid
grew R. terrigena. Interestingly all 10 strains of
R. terrigena isolated by Podschun et al. were in con-
junction with other bacteria, mainly Staphylococcus
aureus and other enterobactericiae.
8 However the
simultaneous isolation of R. terrigena in both
drain ﬂuid and blood culture in our patient, and
sputum and postmortem specimens of aortic
valve in the ﬁrst case report by Goegele et al.
suggests that this organism may be able to cause
mono-microbial infections.
2
Very limited studies have been done on the sen-
sitivity of R. terrigena to antimicrobial agents.
Raoultella spp carry a chromosomal beta-
lactamase that makes this agent naturally resistant
to several antimicrobial agents.
9 R. terrigena in our
case was sensitive to co-amoxiclavulanic acid,
cefotaxime, cefradine, ciproﬂoxacin, gentamicin
and imipenem. Our patient responded well to
piperacillin-tazobactam and imipenem. Podschun
et al. tested 10 strains for their susceptibility to
antimicrobial agents; all strains were susceptible
to cefotaxime, imipenem, co-amoxiclavulanic
acid, doxycycline, gentamicin and ciproﬂoxacin,
as in our case.
8
The correct identiﬁcation of R. terrigena can be
difﬁcult in clinical microbiology laboratories, iso-
lates easily misidentiﬁed as other Klebsiella and
Raoultella species especially Klebsiella pneumo-
niae.
10 This is because most conventional identiﬁ-
cation systems, such as the API 20E, usually fail
to correctly identify these species.
10 Unfortunately,
most of the additional differentiating tests
required for identiﬁcation are uncommon in
routine practice. Differentiation between Klebsiella
pneumoniae and R. terrigena is based mainly on
tests for fermentation of dulcitol, melezitose and
adonitol at 30˚C. Identiﬁcation can be conﬁrmed
by growth at 10˚C and inability to produce gas
from lactose at 44.5˚C.
8 Carbon substrate assimila-
tion systems, such as the API 50 CH, API 50 AO
and API 50 AA galleries, have identiﬁed Klebsiella
isolates to the species level, but the great number
of tests that have to be performed is time-
consuming and the galleries are expensive.
10
Differentalgorithmshave beensuggestedtocor-
rectly identify Klebsiella and Raoultella species. A
combination of two conventional tests (indole and
ornithine decarboxylase tests) and fourcarbon sub-
strate assimilation tests (ethanolamine, histamine,
D-melezitose, and DL-3-hydroxybutyrate tests)
has been suggested. This method achieved a
sensitivity of 94.7% and speciﬁcity of 100% for
these species. Another alternative method could
be routine histamine assimilation testing to
detect Raoultella species among Klebsiella isolates,
followed by the use of conventional tests (i.e.
indole and ornithine decarboxylase tests) on these
Raoultella species to differentiate to the species
level.
3
We identiﬁed this organism by using API20E
(probability 71.5%) and VITEK 2 (probability
98%). It was conﬁrmed by the reference laboratory
using speciﬁc PCR (polymerase chain reaction)
and 16S sequencing.
For the initial identiﬁcation of this organism, we
recommend commercially available identiﬁcation
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2systems which use a combination of biochemical
tests and database. Most modern laboratories
have access to these systems. The deﬁnite identiﬁ-
cation can be done using PCR and sequencing.
Conclusion
R. terrigena is a rarely encountered gram-negative
rod and many microbiological laboratories still
do not subtype Klebsiella and Raoultella spp
beyond the species level. Although occurring
occasionally in human tissues, the clinical signiﬁ-
cance of the presence of R. terrigena is dubious.
However the isolation rate appears to be very
low. We do not suggest that extending the range
of standard tests for R. terrigena identiﬁcation is
warranted in the routine clinical microbiological
laboratory at present. However more research is
needed to understand the spectrum of diseases
caused by this organism.
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